Continuous Processing Optimization with Smarter Tools
Posted on November 7, 2017
Barbara Paldus, PhD., Vice President and General Manager
Finesse, a part of Thermo Fisher Scientific, Santa Clara, California
Due to a paradigm shift in the pharmaceutical industry, there is rising pressure to come up with faster, more cost-effective ways to produce drugs for the patients who need them. As orphan drugs and personalized medicine begin to replace traditional blockbuster products, pharmaceutical companies are...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Related Topics and Keywords
automation, Barb, biosimilars, blockbuster products, CIP, clean-in-place, continuous processing configuration, CONTINUOUS PROCESSING OPTIMIZATION, end-to-end processing, fed batch models, Finesse Solutions, modular automation system, orphan drugs, personalized medicine, single-use technology, SIP, SMARTER TOOLS, sterilization-in-place, SUT
Related Product Videos
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy
